These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26023149)

  • 1. Viroporins: structure, function and potential as antiviral targets.
    Scott C; Griffin S
    J Gen Virol; 2015 Aug; 96(8):2000-2027. PubMed ID: 26023149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in computational studies on influenza a virus M2 proton channel.
    Wang JF; Chou KC
    Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Put a cork in it: Plugging the M2 viral ion channel to sink influenza.
    Jalily PH; Duncan MC; Fedida D; Wang J; Tietjen I
    Antiviral Res; 2020 Jun; 178():104780. PubMed ID: 32229237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minimalist architectures of viroporins and their therapeutic implications.
    OuYang B; Chou JJ
    Biochim Biophys Acta; 2014 Apr; 1838(4):1058-67. PubMed ID: 24055819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viroporins in the Influenza Virus.
    To J; Torres J
    Cells; 2019 Jun; 8(7):. PubMed ID: 31261944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.
    Gargan S; Stevenson NJ
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
    Li F; Ma C; DeGrado WF; Wang J
    J Med Chem; 2016 Feb; 59(3):1207-16. PubMed ID: 26771709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals for influenza: historical perspectives and lessons learned.
    Hayden FG
    Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.
    Li F; Hu Y; Wang Y; Ma C; Wang J
    J Med Chem; 2017 Feb; 60(4):1580-1590. PubMed ID: 28182419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2 protein from influenza A: from multiple structures to biophysical and functional insights.
    Cross TA; Dong H; Sharma M; Busath DD; Zhou HX
    Curr Opin Virol; 2012 Apr; 2(2):128-33. PubMed ID: 22482709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.
    Sulli C; Banik SS; Schilling J; Moser A; Xiang X; Payne R; Wanless A; Willis SH; Paes C; Rucker JB; Doranz BJ
    J Virol; 2013 Oct; 87(19):10679-86. PubMed ID: 23885079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oligomeric state of the active BM2 ion channel protein of influenza B virus.
    Balannik V; Lamb RA; Pinto LH
    J Biol Chem; 2008 Feb; 283(8):4895-904. PubMed ID: 18073201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flu channel drug resistance: a tale of two sites.
    Pielak RM; Chou JJ
    Protein Cell; 2010 Mar; 1(3):246-58. PubMed ID: 21203971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.
    Wang J; Qiu JX; Soto C; DeGrado WF
    Curr Opin Struct Biol; 2011 Feb; 21(1):68-80. PubMed ID: 21247754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.